160 related articles for article (PubMed ID: 37539572)
21. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
22. Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients.
Zhao J; Bian D; Liao H; Wang Y; Ren Y; Jiang Y; Liu S; Chen X; Hu Z; Duan Z; Lu F; Zheng S
Front Cell Infect Microbiol; 2023; 13():1083912. PubMed ID: 37065191
[TBL] [Abstract][Full Text] [Related]
23. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
Liu SQ; Zhu XJ; Sun XH; Li M; Gao YQ
Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
[TBL] [Abstract][Full Text] [Related]
25. Liver histology of treatment-naïve children with chronic hepatitis B virus infection in Shanghai China.
Hu Y; Wu X; Ye Y; Ye L; Han S; Wang X; Yu H
Int J Infect Dis; 2022 Oct; 123():112-118. PubMed ID: 36028208
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of the predictive value of plateletcrit for the degree of liver fibrosis in patients with chronic HBV infection with ALT less than two times the upper limit of normal].
Wang B; Li Y; Xiao L; Xu HT; Xian JC
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):862-868. PubMed ID: 37723069
[No Abstract] [Full Text] [Related]
27. Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT.
Wu Z; Ma AL; Xie Q; Zhang XQ; Cheng J; Zhang DZ; Wang GQ; Zhao H
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101463. PubMed ID: 32571749
[TBL] [Abstract][Full Text] [Related]
28. HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
Praneenararat S; Chamroonkul N; Sripongpun P; Kanngurn S; Jarumanokul R; Piratvisuth T
BMC Gastroenterol; 2014 Dec; 14():218. PubMed ID: 25523185
[TBL] [Abstract][Full Text] [Related]
29. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
30. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
[TBL] [Abstract][Full Text] [Related]
31. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
Li Q; Lu C; Li W; Huang Y; Chen L
Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of liver pathological characteristics and exploration of noninvasive markers of liver fibrosis in children with chronic hepatitis B].
Liang CF; Chang YN; Peng XR; He Y; Chen M; Peng ML; Hu P; Ren H; Xu HM
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):551-557. PubMed ID: 34225430
[No Abstract] [Full Text] [Related]
33. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
34. [Liver histological status and clinic outcome in HBeAg-negative chronic hepatitis B with low viral load].
Deng DL; Jiang JN; Su MH; Wang RM; Zang WW; Ling XZ; Wei HL; Liang XS; Zhou HK; He WM; Guo RS
Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):1013-1017. PubMed ID: 34865348
[No Abstract] [Full Text] [Related]
35. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
Demirören K; Kocamaz H; Doğan Y
Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of clinical characteristics and risk factors of hepatic fibrosis in children with chronic hepatitis B combined with metabolic-related fatty liver disease].
Li W; Jiang LN; Zhao BK; Liu HY; Zhao JM
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):601-607. PubMed ID: 37400384
[No Abstract] [Full Text] [Related]
37. [Analysis of efficacy and factors influencing sequential combination therapy with tenofovir alafenamide fumarate after treatment with entecavir in chronic hepatitis B patients with low-level viremia].
Liu LP; Wu XP; Cai TP; Wang L; Sun J; Liang JY; Ma SP; Gan X; Ruan NH; Ge SF
Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):118-125. PubMed ID: 37137825
[No Abstract] [Full Text] [Related]
38. ALT Levels in Treatment-Naive, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A US Nationwide Study.
Chang CY; Kam L; Dang N; Cheung R; Nguyen MH
Dig Dis; 2022; 40(4):497-505. PubMed ID: 34348281
[TBL] [Abstract][Full Text] [Related]
39. Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis.
Liu J; Wang J; Yan X; Xue R; Zhan J; Jiang S; Geng Y; Liu Y; Mao M; Xia J; Yin S; Tong X; Chen Y; Ding W; Huang R; Wu C
Hepatol Commun; 2022 Apr; 6(4):855-866. PubMed ID: 34783181
[TBL] [Abstract][Full Text] [Related]
40. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis.
Chao DT; Lim JK; Ayoub WS; Nguyen LH; Nguyen MH
Aliment Pharmacol Ther; 2014 Feb; 39(4):349-58. PubMed ID: 24387289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]